It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Telomere length (TL) is linked to various age-related diseases, but little is known about telomeres in gestational diabetes mellitus (GDM). We surveyed 509 subjects (113 GDM patients and 396 frequency matched controls) in Nanjing Drum Tower Hospital, Jiangsu province of eastern China. Relative telomere length (RTL) of genomic DNA extracted from peripheral blood leukocytes was measured using quantitative polymerase chain reaction (qPCR). Odds ratios (OR) and 95% confidence interval (CI) of GDM risk were calculated across tertiles of RTL using logistic regression model. Lipid parameters during the third trimesters of gestation (after 32 weeks) were collected from medical records. The general linear correlation test was used to explore the associations of lipid parameters with RTL. Our results showed that the RTL in GDM patients were significantly shorter than controls (0.302 ± 0.112 vs. 0.336 ± 0.164, P = 0.046). However, the GDM risk was significantly increased in subjects with median RTL (adjusted OR [aOR]: 1.936, 95% CI: 1.086, 3.453, P = 0.025) and the shortest RTL (aOR: 1.795, 95% CI: 1.004, 3.207, P = 0.048), compared to subjects with longest RTL. We also demonstrated that the lipid ratios (TC/TG, LDL/TG, HDL/TG, LDL/TC, TC/LDL) were significantly associated with RTL among controls. Overall, the present study indicated that attrition of telomeres would increase GDM risk among pregnant women, and the altered lipid levels may play an important role in RTL related GDM risk and pathogenesis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Nanjing Medical University, Drum Tower Clinical Medical College, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984); Affiliated Hospital of Nanjing University Medical School, Nanjing Drum Tower Hospital, Nanjing, China (GRID:grid.428392.6) (ISNI:0000 0004 1800 1685); Affiliated to Nanjing University Medical School, Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Nanjing, China (GRID:grid.428392.6)
2 Nanjing Medical University, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984)
3 Nanjing Medical University, Drum Tower Clinical Medical College, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984); Affiliated to Nanjing University Medical School, Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Nanjing, China (GRID:grid.89957.3a)
4 Nanjing Medical University, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984); Nanjing Medical University, State Key Laboratory of Reproductive Medicine, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984)